![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Escandine
2. Ibopamine Hydrochloride
3. Inopamil
4. N-methyldopamine Diisobutyrate
5. Propanoic Acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene Ester
6. Sb 7505
7. Sb-7505
1. 66195-31-1
2. Sb 7505
3. 4-(2-(methylamino)ethyl)-o-phenylene Diisobutyrate
4. 8zca2i2l11
5. Propanoic Acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene Ester
6. Sb-7505
7. Ibopamino [inn-spanish]
8. Sb 7505; Sb 7505 (pharmaceutical); Skf 100168
9. Ibopaminum
10. Ibopamino
11. 4-(2-(methylamino)ethyl)-1,2-phenylene Bis(2-methylpropanoate)
12. Ibopaminum [inn-latin]
13. Einecs 266-229-5
14. Skf 100168
15. Unii-8zca2i2l11
16. Ibopamine [usan:inn:ban]
17. Trazyl
18. 4-(2-(methylamino)ethyl)-2-phenylendiisobutyrat
19. Ibopamine [inn]
20. Ibopamine [mi]
21. Ibopamine (usan/inn)
22. Ibopamine [usan]
23. Ibopamine [mart.]
24. [4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate
25. Ibopamine [who-dd]
26. Schembl147258
27. Chembl307739
28. Dtxsid3023138
29. Chebi:135306
30. Zinc1542906
31. Db13316
32. D04488
33. L013392
34. Q5984366
35. 4-[2-(methylamino)ethyl]benzene-1,2-diyl Bis(2-methylpropanoate)
36. 5-[2-(methylamino)ethyl]-2-[(2-methylpropanoyl)oxy]phenyl 2-methylpropanoate
Molecular Weight | 307.4 g/mol |
---|---|
Molecular Formula | C17H25NO4 |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 9 |
Exact Mass | 307.17835828 g/mol |
Monoisotopic Mass | 307.17835828 g/mol |
Topological Polar Surface Area | 64.6 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 368 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Diuretics
Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)
Mydriatics
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)
C - Cardiovascular system
C01 - Cardiac therapy
C01C - Cardiac stimulants excl. cardiac glycosides
C01CA - Adrenergic and dopaminergic agents
C01CA16 - Ibopamine
S - Sensory organs
S01 - Ophthalmologicals
S01F - Mydriatics and cycloplegics
S01FB - Sympathomimetics excl. antiglaucoma preparations
S01FB03 - Ibopamine